本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kura Oncology, Inc

10.85
-0.3550-3.17%
盘后10.75-0.1000-0.92%17:08 EST
成交量:272.05万
成交额:3,014.78万
市值:9.44亿
市盈率:-4.37
高:11.50
开:11.16
低:10.77
收:11.21
52周最高:16.68
52周最低:5.41
股本:8,701.75万
流通股本:6,398.56万
量比:0.97
换手率:4.25%
股息:- -
股息率:- -
每股收益(TTM):-2.4801
每股收益(LYR):-2.0193
净资产收益率:-65.10%
总资产收益率:-26.57%
市净率:3.89
市盈率(LYR):-5.37

数据加载中...

2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

SEC问询函

Form CORRESP - Correspondence
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

重要事件披露

Form 8-K - Current report
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/02

重要事件披露

Form 8-K - Current report
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report